MGC Pharmaceuticals Limited

MGC Pharmaceuticals Ltd (ASX: MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines to patients globally.
Deal price
21p
Discount of 65% %
Last Price 65p p

Key information

Key information

Sector

Pharmaceuticals

Close date

Delivery

Placing price

Last price

Discount

Amount raised

21p

65 p

65% %

£6.25m

Use of proceeds

https://www.londonstockexchange.com/news-article/MXC/mgc-secures-us-7-9-million-in-firm-commitments/16191939

Important notices

This website contains links to other websites and resources provided by third parties. These links are provided for your information only and we accept no responsibility for them or for any loss or damage that may arise from your use of them.

Investing in financial products involves taking risk. The value of investments can go up as well as down and you may receive back less than your original investment. CMC Markets UK plc trading as CMC CapX (“CMC”) does not provide investment advice of any kind and individual investors should make their own decisions or seek independent advice regarding the merits of entering into, and the suitability of, any investment. Nothing on this website and no communication from CMC should be construed as an investment recommendation. Only professional clients and eligible counterparties are eligible to participate in any offering in connection with CMC's services. There are inherent risks associated with investing in such offerings and such investments should only be made as part of a diversified portfolio. Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful.

Please read our Risk Warning before making any investment decisions.

Capx

Participate in exclusive deals

Start investing in exclusive deals.